Search Clinical Trials
598,002 trials
ID
Status
Phase
Title
Sponsor
NCT07761299
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical LtdNot Yet Recruiting
NCT07761299Not Yet Recruiting
—
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective StudyCMR Surgical Ltd
NCT07759908
Effects of a Synbiotic Intervention on Perimenopausal/Menopausal SymptomsAtlantia Food Clinical TrialsCompletedNot Applicable
NCT07759908Completed
Not Applicable
Effects of a Synbiotic Intervention on Perimenopausal/Menopausal SymptomsAtlantia Food Clinical Tr...
NCT07761858
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on Social Appearance Anxiety in Patients Undergoing Cosmetic SurgeryAydin Adnan Menderes UniversityActive Not Recruiting
NCT07761858Active Not Recruiting
—
AI-Powered Beauty Perceptions and Social Media Awareness Regarding Appearance on...Aydin Adnan Menderes Univ...
NCT07760948
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes AssociationNot Yet RecruitingPhase 2
NCT07760948Not Yet Recruiting
Phase 2
HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting SemaglutideAmerican Diabetes Associa...
NCT07760519
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adults With Resectable NSCLCAstraZenecaNot Yet Recruiting
NCT07760519Not Yet Recruiting
—
A Multicenter Observational PMS Study Assessing Durvalumab Safety in Indian Adul...AstraZeneca
NCT07759544
I-OPERA: A European Study Testing a New Way to Do Health Research.IQVIA RDS Spain, SLNot Yet Recruiting
NCT07759544Not Yet Recruiting
—
I-OPERA: A European Study Testing a New Way to Do Health Research.IQVIA RDS Spain, SL
NCT07761130
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke (iHeLP)Health Research Board, IrelandCompletedNot Applicable
NCT07761130Completed
Not Applicable
A Feasibility Study of the Improving Health and Lifestyle Programme After Stroke...Health Research Board, Ir...
NCT07759882
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care SettinGs in Arkansas (STRONG Moms)University of ArkansasNot Yet RecruitingNot Applicable
NCT07759882Not Yet Recruiting
Not Applicable
Screening & TReatment fOr Perinatal WomeN With PTSD in Substance Use Care Settin...University of Arkansas
NCT07760077
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceutical Research and Development Center LTDNot Yet RecruitingPhase 1
NCT07760077Not Yet Recruiting
Phase 1
Phase I Study of QLS1510 Tablets in Healthy ParticipantsShanghai Qilu Pharmaceuti...
NCT07761286
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection for Hepatocellular CarcinomaCSPC Megalith Biopharmaceutical Co.,Ltd.Not Yet RecruitingPhase 1
NCT07761286Not Yet Recruiting
Phase 1
Evaluate the Safety and Efficacy of Combination Therapy With SYS6090 Injection f...CSPC Megalith Biopharmace...
NCT07760571
Screen-delivered Augmented-reality Preparation and Anxiety Before Pediatric Adenotonsillectomy in ChinaCentral South UniversityCompletedNot Applicable
NCT07760571Completed
Not Applicable
Screen-delivered Augmented-reality Preparation and Anxiety Before Pediatric Aden...Central South University
NCT07761013
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chinese MedicineNot Yet RecruitingNot Applicable
NCT07761013Not Yet Recruiting
Not Applicable
Yanlishuang Buccal Dropping Pills for Acute PharyngitisBeijing University of Chi...
NCT07760155
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibody, ESG206, in Patients With Systemic Lupus ErythematosusShanghai Escugen Biotechnology Co., LtdNot Yet RecruitingPhase 2
NCT07760155Not Yet Recruiting
Phase 2
A Phase 2 Study on the Safety and Efficacy of the Anti-BAFF-R Monoclonal Antibod...Shanghai Escugen Biotechn...
NCT07761702
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-Risk AMLShanghai Jiao Tong University School of MedicineNot Yet RecruitingPhase 3
NCT07761702Not Yet Recruiting
Phase 3
Umbilical Cord Blood Consolidation for Older Adults With Intermediate- and High-...Shanghai Jiao Tong Univer...
NCT07761468
Standardization of IMT Dosage (UTIT) in Mechanical Ventilation.Hospital H+ QueretaroEnrolling By InvitationNot Applicable
NCT07761468Enrolling By Invitation
Not Applicable
Standardization of IMT Dosage (UTIT) in Mechanical Ventilation.Hospital H+ Queretaro
NCT07760870
Development of a Genetic Score as a Response Modifier for Changes in Weight, Body Composition, and Biochemical Parameters in Obese Adults Undergoing a Low-Energy High-Protein Diet InterventionFaculty of Medicine, Gadjah Mada UniversityNot Yet RecruitingNot Applicable
NCT07760870Not Yet Recruiting
Not Applicable
Development of a Genetic Score as a Response Modifier for Changes in Weight, Bod...Faculty of Medicine, Gadj...
NCT07759843
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo UniversityRecruiting
NCT07759843Recruiting
—
Evaluating AI for Diagnosing and Treating Gummy Smiles: A Pilot StudyCairo University
NCT07760792
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial ColonizationAl-Azhar UniversityNot Yet Recruiting
NCT07760792Not Yet Recruiting
—
Risk Factors and Clinical Implications of Double-J Ureteral Stent Bacterial Colo...Al-Azhar University
NCT07761260
BSPTS and Core Stabilization Exercises in Adolescents With Idiopathic ScoliosisIstinye UniversityNot Yet RecruitingNot Applicable
NCT07761260Not Yet Recruiting
Not Applicable
BSPTS and Core Stabilization Exercises in Adolescents With Idiopathic ScoliosisIstinye University
NCT07759258
Plasma GLP-2 Dynamics and Acute Radiation Enteritis After Abdominopelvic RadiotherapyWang XinyingNot Yet Recruiting
NCT07759258Not Yet Recruiting
—
Plasma GLP-2 Dynamics and Acute Radiation Enteritis After Abdominopelvic Radioth...Wang Xinying
Result Breakdown
Not yet recruiting14 (70%)
Completed3 (15%)
Active, not recruiting1 (5%)
Enrolling by invitation1 (5%)
Recruiting1 (5%)
not_applicable8 (40%)
Not Specified7 (35%)
Phase 22 (10%)
Phase 12 (10%)
Phase 31 (5%)